SEATTLE–(BUSINESS WIRE)–#CellCultureMonitoringBiosensors–According to Coherent Market Insights, the global cell culture monitoring biosensors market is estimated to be valued at US$ 332.0 Mn in 2020 and is expected to exhibit a CAGR of 9.6% during the forecast period (2020-2027).
Key Trends and Analysis of the Global Cell Culture Monitoring Biosensors Market:
Increasing R&D in the field of biotechnology and the rising demand for targeted therapies such as biologics and biosimilar are some of the factors driving growth of the global cell culture monitoring biosensors market. For instance, according to News Medical Life-sciences, an online, open-access medical information provider for healthcare and life science professionals, in 2017, researchers were inclined towards developing culture models that can be used for early treatment of age-related macular degeneration (AMD). AMD is the third-major cause for total vision loss and is more prevalent among the geriatric population. Similarly, according to Biotechnology Innovation Organization (BIO) 2015, over 250 biologic therapies and vaccines have changed the lives of hundreds of millions of patients. Moreover, according to the same source, in 2018, over 900 biologics were in developmental stage for over 100 diseases in the U.S.
Moreover, increased production of biotechnology products and creating awareness about cell culture monitoring biosensors are expected to gain significant traction in the market. For instance, biosensors play an important role in CAR-T cell development, as biosensors help to detect abundant types of T cells present in blood. Furthermore, patient’s T cells are modified in the laboratory, so that T cells can inhibit growth of cancer cells.
Furthermore, in August 2018, Novartis received European Commission approval for its CAR-T cell therapy, Kymriah (tisagenlecleucel) for the treatment of pediatric and young adult patients up to 25 years of age with B-cell acute lymphoblastic leukemia. In October 2017, Gilead received the U.S. Food and Drug Administration approval for Yescarta (axicabtagene ciloleucel) for the treatment of relapsed or refractory large B-cell lymphoma. (Read more…)
Request Sample Copy of this Report @ https://www.coherentmarketinsights.com/insight/request-sample/219
Key Market Takeaways:
The global cell culture monitoring biosensors market is expected to exhibit a CAGR of 9.6% during the forecast period (2020-2027), owing to increasing cell culture applications in research and product development
The growth of the North America cell culture monitoring biosensors market is attributed to launch of new products in the region. In March 2018, Lonza launched the Quasi Vivo System, a technologically advanced, interconnected fluidics system, which creates physiologically applicable cell-culture conditions that help researchers improve the predictive value of their studies.
Competitive Landscape:
Key players operating in the global cell culture monitoring biosensors market include C-CIT Sensors AG, Sarissa Biomedical Ltd, Lonza, Lifeonics ltd., Nova Biomedical, Cardea, Conductive Technologies Inc., and Bruker Corporation.
Buy-now this Research Report @ https://www.coherentmarketinsights.com/insight/buy-now/219
Market Segmentation:
-
Global Cell Culture Monitoring Biosensors Market, By Product Type:
- Electrochemical Biosensors
- Thermometric Biosensors
- Fiber Optic Biosensors
- Pizoelectric Biosensors
- Others
-
Global Cell Culture Monitoring Biosensors Market, By End User:
- Pharmaceutical Industry
- Biotechnology Organizations
- Research Laboratories
-
Global Cell Culture Monitoring Biosensors Market, By Region:
-
North America
- U.S.
- Canada
-
Europe
- U.K.
- Germany
- Italy
- Spain
- France
- Russia
- Rest of Europe
-
Asia Pacific
- Australia
- India
- China
- Japan
- ASEAN
- South Korea
- Rest of Asia Pacific
-
Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
-
Middle East
- GCC
- Israel
- Rest of Middle East
-
Africa
- South Africa
- Central Africa
- North Africa
-
North America
Related Market Intelligence Report:
Blood Transfusion Devices Market, by Product Type (Apheresis Systems, Infusion Devices, Blood Warmers, Venous Access Devices, Filters, and Others), by End User (Hospital, Ambulatory Surgical Centers, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) – Size, Share, Outlook, and Opportunity Analysis, 2020 – 2027
Read more: https://www.coherentmarketinsights.com/market-insight/blood-transfusion-devices-market-4156
About Us:
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having sales office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 57 countries worldwide.
Contacts
Mr. Shah
Senior Client Partner – Business Development
Coherent Market Insights
Phone:
US: +1-206-701-6702
UK: +44-020-8133-4027
Japan: +81-050-5539-1737
India: +91-848-285-0837
Email: sales@coherentmarketinsights.com
Website: https://www.coherentmarketinsights.com
Follow Us: LinkedIn | Twitter